Rice SJ - Search Results

1

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.

Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LLS, Warren GW, Xiao SY, Smit EF, Aerts JG, Yoon SH, Veronesi G, De Cobelli F, Ramalingam SS, Garassino MC, Wynes MW, Behera M, Haanen J, Lu S, Peters S, Ahn MJ, Scagliotti GV, Adjei AA, Belani CP. Dingemans AC, et al. Among authors: rice sj. J Thorac Oncol. 2020 Jul;15(7):1119-1136. doi: 10.1016/j.jtho.2020.05.001. Epub 2020 May 15. J Thorac Oncol. 2020. PMID: 32422364 Free PMC article. Review.

2

Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancer.

Joshi M, Rice SJ, Liu X, Miller B, Belani CP. Joshi M, et al. Among authors: rice sj. PLoS One. 2015 Feb 23;10(2):e0118210. doi: 10.1371/journal.pone.0118210. eCollection 2015. PLoS One. 2015. PMID: 25706985 Free PMC article.

3

Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung.

Rice SJ, Liu X, Miller B, Joshi M, Zhu J, Caruso C, Gilbert C, Toth J, Reed M, Rassaei N, Das A, Barochia A, El-Bayoumy K, Belani CP. Rice SJ, et al. Proteomics. 2015 Sep;15(18):3267-77. doi: 10.1002/pmic.201500029. Epub 2015 Jul 3. Proteomics. 2015. PMID: 26058877

4

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives.

Rice SJ, Miller B, Wagman M, Jamorabo DS, Liu X, Belani CP. Rice SJ, et al. Curr Mol Pharmacol. 2016;9(3):183-195. doi: 10.2174/1874467208666150716120108. Curr Mol Pharmacol. 2016. PMID: 26177648 Review.

5

A patient with complex multiple genomic ALK alterations.

Liu X, Rice SJ, Jamis-Dow CA, Abendroth C, Ali S, Almokadem S, Belani CP. Liu X, et al. Among authors: rice sj. Thorax. 2016 Apr;71(4):383-5. doi: 10.1136/thoraxjnl-2015-207950. Epub 2016 Feb 2. Thorax. 2016. PMID: 26839360 No abstract available.

6

Pulmonary Rehabilitation in Lung Cancer.

Wang H, Liu X, Rice SJ, Belani CP. Wang H, et al. Among authors: rice sj. PM R. 2016 Oct;8(10):990-996. doi: 10.1016/j.pmrj.2016.03.010. Epub 2016 Apr 6. PM R. 2016. PMID: 27060645 Review.

7

Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer.

Zheng H, Liu X, Zhang J, Rice SJ, Wagman M, Kong Y, Zhu L, Zhu J, Joshi M, Belani CP. Zheng H, et al. Among authors: rice sj. Oncotarget. 2016 Aug 30;7(35):56233-56240. doi: 10.18632/oncotarget.9316. Oncotarget. 2016. PMID: 27191652 Free PMC article.

8

Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery.

Rice SJ, Liu X, Zhang J, Belani CP. Rice SJ, et al. Proteomics. 2019 Feb;19(3):e1800135. doi: 10.1002/pmic.201800135. Epub 2019 Jan 18. Proteomics. 2019. PMID: 30585401

9

Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling.

Rice SJ, Liu X, Zhang J, Jia B, Zheng H, Belani CP. Rice SJ, et al. Lung Cancer. 2019 May;131:58-61. doi: 10.1016/j.lungcan.2019.03.014. Epub 2019 Mar 18. Lung Cancer. 2019. PMID: 31027698

10

EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer.

Rice SJ, Liu X, Wang HG, Belani CP. Rice SJ, et al. PLoS One. 2019 May 31;14(5):e0217657. doi: 10.1371/journal.pone.0217657. eCollection 2019. PLoS One. 2019. PMID: 31150457 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page